Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Barron · SciRah

Researcher profile · Semantic Scholar

R. Barron

Share profile

R. Barron — researcher profile on SciRah

h-index: 35
Works: 125
Citations: 3,338

Most-cited papers

Risk of mortality in patients with cancer who experience febrile neutropenia
Gary H. Lyman, Shannon L. Michels, M. Reynolds, R. Barron +2 more
2010Cancer237 citations Open access
Semantic Scholar
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices.
N. Denduluri, D. Patt, Yunfei Wang, M. Bhor +9 more
2015The Journal of the National Comprehensive Cancer Network134 citations Open access
Semantic Scholar
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
Li Wang, O. Baser, L. Kutikova, J. Page +1 more
2014Supportive Care in Cancer121 citations Open access
Semantic Scholar
Prevalence of antibiotic resistance in US hospitals.
J. Edelsberg, D. Weycker, R. Barron, Xiaoyan Li +5 more
2014Diagnostic microbiology and infectious disease106 citations
Semantic Scholar
Hospitalizations for osteoporosis-related fractures: Economic costs and clinical outcomes
D. Weycker, Xiaoyan Li, R. Barron, R. Bornheimer +1 more
2016Bone Reports100 citations Open access
Semantic Scholar
Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data
M. Bonafede, N. Shi, R. Barron, Xiaoyan Li +2 more
2016Archives of Osteoporosis96 citations Open access
Semantic Scholar
Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States
Emily Durden, L. Pinto, L. López-González, P. Juneau +1 more
2017Archives of Osteoporosis86 citations Open access
Semantic Scholar
Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer
N. Denduluri, G. Lyman, Yunfei Wang, P. K. Morrow +11 more
2018Clinical Breast Cancer83 citations Open access
Semantic Scholar
A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia
B. Dulisse, Xiaoyan Li, J. Gayle, R. Barron +4 more
2013Journal of Medical Economics82 citations Open access
Semantic Scholar
Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings
D. Weycker, R. Barron, A. Kartashov, Jason C. Legg +1 more
2014Journal of Oncology Pharmacy Practice81 citations
Semantic Scholar
Risk and Consequences of Chemotherapy-Induced Febrile Neutropenia in Patients With Metastatic Solid Tumors.
D. Weycker, Xiaoyan Li, J. Edelsberg, R. Barron +3 more
2015Journal of Oncology Practice78 citations
Semantic Scholar
Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer
J. Crawford, N. Denduluri, D. Patt, X. Jiao +4 more
2019Supportive Care in Cancer74 citations Open access
Semantic Scholar
Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States.
G. Lyman, A. Lalla, R. Barron, R. Dubois
2009Clinical Therapeutics72 citations
Semantic Scholar
Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.
M. Nichol, Tara K. Knight, Joanne Wu, R. Barron +1 more
2009Journal of Urology68 citations
Semantic Scholar
Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.
D. Weycker, J. Malin, John Kim, R. Barron +3 more
2009Clinical Therapeutics68 citations
Semantic Scholar
Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice
D. Weycker, R. Barron, J. Edelsberg, A. Kartashov +1 more
2012Breast Cancer Research and Treatment67 citations
Semantic Scholar
Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review
S. Mitchell, Xiaoyan Li, M. Woods, Jacob Garcia +3 more
2016Journal of Oncology Pharmacy Practice66 citations
Semantic Scholar
Costs Associated with Febrile Neutropenia in the US
Shannon L. Michels, R. Barron, M. Reynolds, K. Tomic +2 more
2012PharmacoEconomics (Auckland)66 citations
Semantic Scholar
Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States
G. Lyman, A. Lalla, R. Barron, R. Dubois
2009Current Medical Research and Opinion66 citations
Semantic Scholar
Comparative Effectiveness of Filgrastim, Pegfilgrastim, and Sargramostim as Prophylaxis Against Hospitalization for Neutropenic Complications in Patients With Cancer Receiving Chemotherapy
D. Weycker, J. Malin, R. Barron, J. Edelsberg +2 more
2012American Journal of Clinical Oncology60 citations
Semantic Scholar
Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study
Hiangkiat Tan, K. Tomic, D. Hurley, Gregory W. Daniel +2 more
2011Current Medical Research and Opinion60 citations
Semantic Scholar
Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries
A. Yusuf, Thomas J Matlon, A. Grauer, R. Barron +2 more
2016Archives of Osteoporosis51 citations
Semantic Scholar
Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter?
D. Weycker, Xiaoyan Li, Jacqueline Figueredo, R. Barron +2 more
2015Supportive Care in Cancer48 citations Open access
Semantic Scholar
Estimating the long-term functional burden of osteoporosis-related fractures
Shira H. Fischer, Kandice A. Kapinos, Andrew W. Mulcahy, L. Pinto +2 more
2017Osteoporosis International44 citations
Semantic Scholar
Risk and Healthcare Costs of Chemotherapy-Induced Neutropenic Complications in Women with Metastatic Breast Cancer
D. Weycker, J. Edelsberg, A. Kartashov, R. Barron +1 more
2012Chemotherapy44 citations Open access
Semantic Scholar
Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis
D. Weycker, R. Barron, J. Edelsberg, A. Kartashov +2 more
2014BMC Health Services Research39 citations Open access
Semantic Scholar
Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian Multicentre Osteoporosis Study (CaMos)
Jonathan D. Adachi, C. Berger, R. Barron, D. Weycker +16 more
2019Archives of Osteoporosis38 citations
Semantic Scholar
Discrete choice experiment to estimate breast cancer patients' preferences and willingness to pay for prophylactic granulocyte colony-stimulating factors.
Phaedra T. Johnson, T. Bancroft, R. Barron, Jason C. Legg +5 more
2014Value in Health38 citations Open access
Semantic Scholar
Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures
D. Weycker, J. Edelsberg, R. Barron, M. Atwood +3 more
2017Osteoporosis International37 citations Open access
Semantic Scholar
Hospitalizations, outcomes, and management costs of febrile neutropenia in patients from a managed care population
A. Kawatkar, A. Farias, C. Chao, Wansu Chen +3 more
2017Supportive Care in Cancer37 citations Open access
Semantic Scholar
Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy‐induced neutropenia
D. Weycker, R. Barron
2010Cancer36 citations Open access
Semantic Scholar
Survey assessment of continuation of and satisfaction with pharmacological treatment for urinary incontinence.
U. Campbell, P. Stang, R. Barron
2008Value in Health35 citations Open access
Semantic Scholar
Predictors of Imminent Risk of Nonvertebral Fracture in Older, High‐Risk Women: The Framingham Osteoporosis Study
M. Hannan, D. Weycker, R. McLean, S. Sahni +4 more
2019JBMR Plus31 citations Open access
Semantic Scholar
Primary vs secondary prophylaxis with pegfilgrastim for the reduction of febrile neutropenia risk in patients receiving chemotherapy for non-Hodgkin’s lymphoma: cost-effectiveness analyses
G. Hill, R. Barron, K. Fust, M. Skornicki +3 more
2014Journal of Medical Economics30 citations Open access
Semantic Scholar
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma
K. Fust, Xiaoyan Li, M. Maschio, G. Villa +6 more
2016PharmacoEconomics (Auckland)29 citations Open access
Semantic Scholar
Predictors of imminent risk of fracture in Medicare-enrolled men and women
A. Yusuf, Yan Hu, D. Chandler, D. Crittenden +1 more
2020Archives of Osteoporosis26 citations Open access
Semantic Scholar
Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis
J. Liu, H. Guo, P. Rai, L. Pinto +1 more
2018Osteoporosis International26 citations
Semantic Scholar
Comparative effectiveness of pegfilgrastim, filgrastim, and sargramostim prophylaxis for neutropenia-related hospitalization: two US retrospective claims analyses
H. Henk, L. Becker, Hiangkiat Tan, J. Yu +4 more
2013Journal of Medical Economics25 citations Open access
Semantic Scholar
Systematic review of efficacy of dose-dense versus non-dose-dense chemotherapy in breast cancer, non-Hodgkin lymphoma, and non-small cell lung cancer.
G. Lyman, R. Barron, J. Natoli, Ross M. Miller
2012Critical reviews in oncology/hematology24 citations
Semantic Scholar
Validated prediction of imminent risk of fracture for older adults.
R. Sheer, R. Barron, L. Sudharshan, M. Pasquale
2020American Journal of Managed Care22 citations
Semantic Scholar
Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens
D. Weycker, Xiaoyan Li, J. Edelsberg, R. Barron +3 more
2014Supportive Care in Cancer22 citations
Semantic Scholar
Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review
S. Fujiwara, A. Miyauchi, Etsuro Hamaya, R. Nicholls +5 more
2018Archives of Osteoporosis20 citations
Semantic Scholar
A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture.
Claire E. O'Hanlon, A. Parthan, M. Kruse, Shannon Cartier +5 more
2017Clinical Therapeutics20 citations Open access
Semantic Scholar
Trends in neutropenia-related inpatient events.
C. Kozma, M. Dickson, V. Chia, Jason C. Legg +1 more
2012Journal of Oncology Practice20 citations Open access
Semantic Scholar
Importance of Risk Factors for Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified as High-Risk in Guidelines for Myeloid Growth Factor Use.
D. Weycker, Xiaoyan Li, R. Barron, Hong-Sheng Wu +6 more
2015The Journal of the National Comprehensive Cancer Network17 citations Open access
Semantic Scholar
Granulocyte colony-stimulating factor (G-CSF) patterns of use in cancer patients receiving myelosuppressive chemotherapy
M. Choi, C. Solid, V. Chia, A. Blaes +3 more
2014Supportive Care in Cancer17 citations
Semantic Scholar
Medical Costs for Osteoporosis‐Related Fractures in High‐Risk Medicare Beneficiaries
Kandice A. Kapinos, Shira H. Fischer, Andrew W. Mulcahy, O. Hayden +1 more
2018Journal of The American Geriatrics Society16 citations
Semantic Scholar
Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice
D. Weycker, Xiaoyan Li, R. Barron, Yanli Li +5 more
2015Supportive Care in Cancer16 citations Open access
Semantic Scholar
Comorbidities among patients with cancer who do and do not develop febrile neutropenia during the first chemotherapy cycle
Xiaoyan Li, Rakesh Luthra, P. K. Morrow, M. Fisher +3 more
2016Journal of Oncology Pharmacy Practice14 citations
Semantic Scholar
Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancer.
K. Fust, Xiaoyan Li, M. Maschio, R. Barron +5 more
2014Gynecologic Oncology12 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Xiaoyan Li×16
Invite
Xiaoyan Li — researcher profile on SciRah
G. Lyman×16
Invite
G. Lyman — researcher profile on SciRah
D. Weycker×16
Invite
D. Weycker — researcher profile on SciRah
A. Kartashov×9
Invite
A. Kartashov — researcher profile on SciRah

×8

Invite

J. Edelsberg — researcher profile on SciRah

Jacob Garcia×6

Invite

Jacob Garcia — researcher profile on SciRah

Invite

D. Chandler — researcher profile on SciRah

P. K. Morrow×5

Invite

P. K. Morrow — researcher profile on SciRah

Jason C. Legg×5

Invite

Jason C. Legg — researcher profile on SciRah

Invite

G. Oster — researcher profile on SciRah

D. Crittenden×4

Invite

D. Crittenden — researcher profile on SciRah

Invite

L. Pinto — researcher profile on SciRah